Author

U. Malhotra

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

C. Speake· 2 shared A. E. L. Stone· 1 shared A. Forero· 1 shared A. M. Hocking· 1 shared A. M. Kell· 1 shared BRI COVID-19 Research Team· 1 shared C. Balu· 1 shared D. B. Stetson· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

C. Speake

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Endomembrane targeting of human OAS1 p46 augments antiviral activity

F. W. Soveg, J. Schwerk, N. S. Gokhale, K. Cerosaletti, J. R. Smith, E. Pairo-Castineira, A. M. Kell, A. Forero, S. A. Zaver, K. Esser-Nobis, J. Roby, T.-Y. Hsiang, S. Ozarkar, J. M. Clingan, E. T. McAnarney, , R. Savan

This study shows that the OAS1 p46 isoform, targeted to the endomembrane system, enhances antiviral activity against RNA viruses and is associated with COVID-19 severity.

bioRxiv · Apr 21, 2021Immunology

The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity

H. Bolouri, C. Speake, D. Skibinski, S. A. Long, A. M. Hocking, D. J. Campbell, J. A. Hamerman, U. Malhotra, J. H. Buckner, BRI COVID-19 Research Team

This study identifies three immune clusters in COVID-19 patients correlated with disease severity and shows that immune responses change dynamically with clinical outcomes.

bioRxiv · Sep 18, 2020Immunology